tetradecanoylphorbol acetate has been researched along with Low Bone Density in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fakruddin, JM; Laurence, J | 1 |
| Lerner, UH; Ransjö, M | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Low Bone Density
| Article | Year |
|---|---|
Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.
Topics: Bone Diseases, Metabolic; Carrier Proteins; Electrophoretic Mobility Shift Assay; HIV Infections; HIV-1; Humans; Interferon-gamma; Interleukin-2; Membrane Glycoproteins; NF-kappa B; Peptides; Proteins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Tetradecanoylphorbol Acetate; TNF Receptor-Associated Factor 6; Tumor Necrosis Factor-alpha; U937 Cells; Virus Activation; Virus Replication | 2004 |
12-O-tetradecanoylphorbol-13-acetate, a phorbol ester stimulating protein kinase C, inhibits bone resorption in vitro induced by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
Topics: Animals; Bone Diseases, Metabolic; Calcium; Mice; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Protein Kinase C; Proteins; Tetradecanoylphorbol Acetate | 1990 |